OmniAb Inc
NASDAQ:OABI
Market Cap (Intraday) | 460.03M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $4.19 |
50-Day MA | $3.67 |
200-Day MA | N/A |
OmniAb Inc Stock, NASDAQ:OABI
5980 Horton Street, Suite 600, Emeryville, California 94608
United States of America
Phone: +1.510.250.7800
Number of Employees:
Description
OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. The firm�s platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.